Douglas T. Sheehy
2018 - Aimmune Therapeutics
In 2018, Douglas T. Sheehy earned a total compensation of $3.2M as General Counsel and Secretary at Aimmune Therapeutics, a 87% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,000 |
|---|---|
| Option Awards | $1,600,335 |
| Salary | $372,883 |
| Stock Awards | $1,107,275 |
| Other | $2,000 |
| Total | $3,247,493 |
Sheehy received $1.6M in option awards, accounting for 49% of the total pay in 2018.
Sheehy also received $165K in non-equity incentive plan, $372.9K in salary, $1.1M in stock awards and $2K in other compensation.
Rankings
In 2018, Douglas T. Sheehy's compensation ranked 3,546th out of 14,244 executives tracked by ExecPay. In other words, Sheehy earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,546 out of 14,244 | 75th |
Division Manufacturing | 1,310 out of 5,765 | 77th |
Major group Chemicals And Allied Products | 459 out of 2,128 | 78th |
Industry group Drugs | 378 out of 1,817 | 79th |
Industry Pharmaceutical Preparations | 291 out of 1,391 | 79th |
Source: SEC filing on April 10, 2019.
Sheehy's colleagues
We found five more compensation records of executives who worked with Douglas T. Sheehy at Aimmune Therapeutics in 2018.
2018
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
2018
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
2018
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
2018
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
2018
Susan Barrowcliffe
Aimmune Therapeutics